Release Date: 23/10/12 08:30 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 376.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%